Equities — earnings, movers, IPOs and sector trends.
The benchmark 10-year yield dropped by over 19 basis points for its largest single-day fall since March 2023, closing in at 4.9591% on October 23 as the AI tech rout pushed investors toward government bonds and long-dated funds gained nearly 2%.
Alphabet, Microsoft and Amazon report this week while the Fed decides on October 28. With hyperscaler capex near $800 billion and S&P 500 profits up over 32%, the AI rally faces its toughest test of the year.
Japan's Nikkei dropped 1.3% on Friday, closing out a brutal 5% weekly loss, as Thursday's Wall Street tech rout spilled across Asia and investors pared bets on further Fed tightening.
Elice shares traded above their 90,500-won IPO price for the first time on Thursday, touching 99,900 won intraday — completing a three-day swing from a 32% debut rout to a 25% rally on Korea's Kosdaq.
NextDC shares collapsed around 40% on Wednesday after the Australian data-centre operator slashed its fiscal 2027 guidance and shelved all new developments, blaming suspended electricity-network upgrades that have left its flagship M3 Melbourne site short of power.
MSCI beat Wall Street on both lines in Q3 2026 — $892 million in revenue and $5.11 in adjusted EPS — as record asset-based fees from its index business did the heavy lifting. The stock jumped 5% to $591.69.
Elice Group plunged as much as 33% on its Kosdaq trading debut — the worst opening day for a sizable Korean IPO — as the Kosdaq's biggest listing of 2026 turned into the poster child for a souring AI-infrastructure trade. The Kospi fell 3.2% as chip heavyweights sagged under heavy foreign selling.
Bill Ackman's Pershing Square has lost a quarter of its value in a week as Citi and Bank of America both turned sellers, calling the post-IPO rally's 54-times earnings multiple unjustifiable.
Reliance's Jio Platforms is raising up to $3.2 billion at ₹1,065–1,119 a share — India's biggest IPO on record. Here are the terms, the timeline, and what the cut valuation means for demand.
Bristol Myers Squibb stock is up about 40% over the past year, yet BMY changes hands under 10 times forward earnings. Q2's growth-portfolio numbers and the October 29 Q3 report decide whether that discount survives.
Sahajanand Medical Technologies' Rs 475.48-crore IPO enters day 2 with a 12% grey market premium and 34% day-1 subscription, trailing its three mainboard peers on grey market momentum.
Taiwan Semiconductor posted its sixth straight record quarter, with net profit up 68.7% to NT$763.06 billion as AI accelerators took 68% of revenue — and management says leading-edge demand is outrunning supply.
